US$ 28.45
future glp-1 drugs Changed Obesity Treatment. The Next Challenge May Be Clinical Trial Capacity Upcoming wave of hormone-based therapies
Description
INDUSTRY UPDATE Meala FoodTech has partnered with dsm-firmenich to launch Vertis PB Pea, a texturizing pea protein

While certain side effects have been reported more commonly with semaglutide vs
Yoshida K, Solomon DH, Kim SC

All of that makes these drugs more expensive, says Laura Davisson, director of the weight management program at the West Virginia University Health System

Prioritize protein and fiber even when your appetite is reduced
